Towa Pharmaceutical Co., Ltd. · TSE:4553
Towa Pharmaceutical — H1 2007 Earnings Presentation
11 slides from Towa Pharmaceutical's earnings presentation, Nov 9, 2007
Slide 1: Interim Results Briefing 2007 (4553)
2007 2007 11 9 ( 4553)
Slide 2: Interim results summary, September 2007
2007 9 ( ) 07/9 06/9 15,193 + 14.0% 13,324 7,113 46.8% + 18.1% 6,024 45.2% 4,647 30.6% - 0.2% 4,654 34.9% 2,466 16.2% + 80.0% 1,369 10.3% 2,501 16.5% + 64.0% 1,525 11.5% 1,422 9.4% + 69.8% 837 6.3% -1-
Slide 3: Sales change factors, 06/9 to 07/9
04 +190 +177 +244 +189 03 +196 15,193 07 +1,869 +387 06 +486 05 02 13,324 06/9 07/9 -2-
Slide 4: D and CR product trends
(22 ) 1.9 160 07/7 21.5% 2 4 06 (19 ) 140 13 06/7 2 9 11 05/7 02~05 120 4 7 17 4 8 13 04/7 05 (35 ) D 04 (18 ) CR 100 13 20 15 03/7 03 (14 ) 80 02 (23 ) 89 87 02/7 85 60 05/9 06/9 07/9 -3-
Slide 5: Sales breakdown by category
( ) 15 05/9 06/9 07/9 10 5 0 CR -4-
Slide 6: Cost and expense ratios
( ) 10.3% 07/9 61.8% 24.8% 10.2% 3.1% 07/3 63.0% 23.7% 10.8% 3.0% 06/9 61.8% 23.6% 3.8% 11.2% 06/3 64.0% 21.2% 3.5% 11.4% 05/9 65.1% 19.7% 3.8% -5-
Slide 7: Operating profit analysis
( ) 07/9 2,425 185 z (2,240) 784 236 (1,020) z BE 387 15 (371) 1,050 28 (1,022) 4,647 7 (4,654) -6-
Slide 8: Income statement summary
( ) 07/9 06/9 15,193 13,324 z 7,113 6,024 (0.43 ) 4,647 4,654 2,466 1,369 z 29 214 281 138 07/3 117.05 /$ 179 125 07/9 114.43 /$ 29 2,501 1,525 13 15 z 177 116 177 1,422 837 -7-
Slide 9: Balance sheet as of 07/3 and 07/9
( ) 07/9 07/3 1,780 1,179 +600 07 3 11,193 11,801 608 1,422 316 +1,106 7,858 8,215 357 614 644 29 1,075 1,223 148 23,942 23,378 +563 19,530 20,289 759 43,473 43,668 195 3,174 4,066 891 4,908 5,211 303 8,082 9,277 1,195 1,172 1,120 +52 9,254 10,397 1,143 34,218 33,270 +947 43,473 43,668 195 -8-
Slide 10: Full-year forecast for fiscal year ending 08/3
( ) 08/3 ( ) 07/3 32,400 + 10.8% 29,235 5,600 17.3% + 26.8% 4,416 15.1% 5,800 17.9% + 18.7% 4,886 16.7% 3,550 11.0% + 36.6% 2,598 8.9% -9-
Slide 11: Contact: TEL / FAX
TEL 06-6900-9101 FAX 06-6900-0634 -10-